vs

Side-by-side financial comparison of NATIONAL BANKSHARES INC (NKSH) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

NATIONAL BANKSHARES INC is the larger business by last-quarter revenue ($15.3M vs $13.2M, roughly 1.2× TriSalus Life Sciences, Inc.). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -73.9%, a 112.4% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 24.7%). NATIONAL BANKSHARES INC produced more free cash flow last quarter ($15.2M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 20.9%).

Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

NKSH vs TLSI — Head-to-Head

Bigger by revenue
NKSH
NKSH
1.2× larger
NKSH
$15.3M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+35.2% gap
TLSI
59.8%
24.7%
NKSH
Higher net margin
NKSH
NKSH
112.4% more per $
NKSH
38.5%
-73.9%
TLSI
More free cash flow
NKSH
NKSH
$17.7M more FCF
NKSH
$15.2M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
20.9%
NKSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NKSH
NKSH
TLSI
TLSI
Revenue
$15.3M
$13.2M
Net Profit
$5.9M
$-9.8M
Gross Margin
86.7%
Operating Margin
47.4%
-24.8%
Net Margin
38.5%
-73.9%
Revenue YoY
24.7%
59.8%
Net Profit YoY
91.0%
3.5%
EPS (diluted)
$0.93
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NKSH
NKSH
TLSI
TLSI
Q4 25
$15.3M
$13.2M
Q3 25
$14.2M
$11.6M
Q2 25
$13.3M
$11.2M
Q1 25
$12.8M
$9.2M
Q4 24
$12.2M
$8.3M
Q3 24
$11.7M
$7.3M
Q2 24
$10.9M
$7.4M
Q1 24
$10.4M
$6.5M
Net Profit
NKSH
NKSH
TLSI
TLSI
Q4 25
$5.9M
$-9.8M
Q3 25
$4.4M
$-10.8M
Q2 25
$2.3M
$-8.3M
Q1 25
$3.2M
$-10.4M
Q4 24
$3.1M
$-10.1M
Q3 24
$2.7M
$-2.4M
Q2 24
$-307.0K
$-4.3M
Q1 24
$2.2M
$-13.2M
Gross Margin
NKSH
NKSH
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
NKSH
NKSH
TLSI
TLSI
Q4 25
47.4%
-24.8%
Q3 25
37.9%
-77.9%
Q2 25
20.0%
-65.4%
Q1 25
30.5%
-79.9%
Q4 24
30.1%
-91.8%
Q3 24
27.5%
-118.9%
Q2 24
-4.4%
-111.0%
Q1 24
25.8%
-180.8%
Net Margin
NKSH
NKSH
TLSI
TLSI
Q4 25
38.5%
-73.9%
Q3 25
31.1%
-93.5%
Q2 25
17.2%
-73.9%
Q1 25
25.3%
-113.2%
Q4 24
25.1%
-122.4%
Q3 24
22.8%
-32.6%
Q2 24
-2.8%
-58.8%
Q1 24
20.8%
-204.5%
EPS (diluted)
NKSH
NKSH
TLSI
TLSI
Q4 25
$0.93
$-0.22
Q3 25
$0.69
$-0.96
Q2 25
$0.36
$-0.27
Q1 25
$0.51
$-0.39
Q4 24
$0.50
$-0.38
Q3 24
$0.42
$-0.12
Q2 24
$-0.05
$-0.21
Q1 24
$0.37
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NKSH
NKSH
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$59.3M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$184.9M
$-33.9M
Total Assets
$1.8B
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NKSH
NKSH
TLSI
TLSI
Q4 25
$59.3M
$20.4M
Q3 25
$42.3M
$22.7M
Q2 25
$92.8M
$26.5M
Q1 25
$122.5M
$13.0M
Q4 24
$108.1M
$8.5M
Q3 24
$49.8M
$11.3M
Q2 24
$98.9M
$16.5M
Q1 24
$121.2M
$4.0M
Stockholders' Equity
NKSH
NKSH
TLSI
TLSI
Q4 25
$184.9M
$-33.9M
Q3 25
$179.2M
$-26.7M
Q2 25
$168.7M
$-19.4M
Q1 25
$167.3M
$-34.4M
Q4 24
$156.4M
$-25.9M
Q3 24
$167.8M
$-20.4M
Q2 24
$149.0M
$-25.3M
Q1 24
$139.4M
$-36.0M
Total Assets
NKSH
NKSH
TLSI
TLSI
Q4 25
$1.8B
$35.3M
Q3 25
$1.8B
$36.5M
Q2 25
$1.8B
$41.3M
Q1 25
$1.8B
$28.6M
Q4 24
$1.8B
$24.0M
Q3 24
$1.8B
$27.5M
Q2 24
$1.8B
$32.4M
Q1 24
$1.7B
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NKSH
NKSH
TLSI
TLSI
Operating Cash FlowLast quarter
$17.9M
$-2.5M
Free Cash FlowOCF − Capex
$15.2M
$-2.5M
FCF MarginFCF / Revenue
99.2%
-19.1%
Capex IntensityCapex / Revenue
17.9%
0.3%
Cash ConversionOCF / Net Profit
3.04×
TTM Free Cash FlowTrailing 4 quarters
$23.6M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NKSH
NKSH
TLSI
TLSI
Q4 25
$17.9M
$-2.5M
Q3 25
$6.1M
$-3.7M
Q2 25
$2.1M
$-7.3M
Q1 25
$2.6M
$-4.5M
Q4 24
$9.4M
$-5.7M
Q3 24
$3.1M
$-10.8M
Q2 24
$-3.0M
$-13.4M
Q1 24
$3.8M
$-10.9M
Free Cash Flow
NKSH
NKSH
TLSI
TLSI
Q4 25
$15.2M
$-2.5M
Q3 25
$5.3M
$-3.9M
Q2 25
$1.5M
$-7.4M
Q1 25
$1.6M
$-5.3M
Q4 24
$6.2M
$-5.8M
Q3 24
$2.2M
$-11.0M
Q2 24
$-4.0M
$-13.5M
Q1 24
$3.5M
$-10.9M
FCF Margin
NKSH
NKSH
TLSI
TLSI
Q4 25
99.2%
-19.1%
Q3 25
37.4%
-33.9%
Q2 25
11.5%
-66.1%
Q1 25
12.5%
-57.3%
Q4 24
50.5%
-69.7%
Q3 24
18.5%
-149.9%
Q2 24
-36.3%
-183.1%
Q1 24
33.8%
-169.3%
Capex Intensity
NKSH
NKSH
TLSI
TLSI
Q4 25
17.9%
0.3%
Q3 25
5.6%
1.9%
Q2 25
4.1%
0.8%
Q1 25
7.5%
8.2%
Q4 24
26.6%
0.6%
Q3 24
8.3%
2.3%
Q2 24
9.3%
0.8%
Q1 24
3.0%
1.0%
Cash Conversion
NKSH
NKSH
TLSI
TLSI
Q4 25
3.04×
Q3 25
1.38×
Q2 25
0.90×
Q1 25
0.79×
Q4 24
3.07×
Q3 24
1.17×
Q2 24
Q1 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons